These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7005446)

  • 1. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
    Dietrich SW; Blaney JM; Reynolds MA; Jow PY; Hansch C
    J Med Chem; 1980 Nov; 23(11):1205-12. PubMed ID: 7005446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
    Li RL; Dietrich SW; Hansch C
    J Med Chem; 1981 May; 24(5):538-44. PubMed ID: 7017146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationship of 5-(X-benzyl)-2,4-diaminopyrimidines inhibiting bovine liver dihydrofolate reductase.
    Blaney JM; Dietrich SW; Reynolds MA; Hansch C
    J Med Chem; 1979 Jun; 22(6):614-7. PubMed ID: 458817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines.
    Li RL; Poe M
    J Med Chem; 1988 Feb; 31(2):366-70. PubMed ID: 3276891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the inhibitory action of 5-(substituted-benzyl)-2,4-diaminopyrimidines on dihydrofolate reductase from chicken liver with that from bovine liver.
    Li R; Hansch C; Kaufman BT
    J Med Chem; 1982 Apr; 25(4):435-40. PubMed ID: 7069722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase.
    Selassie CD; Li RL; Poe M; Hansch C
    J Med Chem; 1991 Jan; 34(1):46-54. PubMed ID: 1899453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysis.
    Selassie CD; Fang ZX; Li RL; Hansch C; Klein T; Langridge R; Kaufman BT
    J Med Chem; 1986 May; 29(5):621-6. PubMed ID: 3701780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
    Selassie CD; Fang ZX; Li RL; Hansch C; Debnath G; Klein TE; Langridge R; Kaufman BT
    J Med Chem; 1989 Aug; 32(8):1895-905. PubMed ID: 2502631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-activity analysis.
    Hansch C; Li R; Blaney JM; Langridge R
    J Med Chem; 1982 Jul; 25(7):777-84. PubMed ID: 6809941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear quantitative structure-activity relationship for the inhibition of dihydrofolate reductase by pyrimidines.
    Hirst JD
    J Med Chem; 1996 Aug; 39(18):3526-32. PubMed ID: 8784450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theory and application of molecular potential energy fields in molecular shape analysis: a quantitative structure--activity relationship study of 2,4-diamino-5-benzylpyrimidines as dihydrofolate reductase inhibitors.
    Hopfinger AJ
    J Med Chem; 1983 Jul; 26(7):990-6. PubMed ID: 6345782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 7. Analysis of the effect of 3,5-dialkyl substituent size and shape on binding to four different dihydrofolate reductase enzymes.
    Roth B; Rauckman BS; Ferone R; Baccanari DP; Champness JN; Hyde RM
    J Med Chem; 1987 Feb; 30(2):348-56. PubMed ID: 3100802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetroxoprim--a new inhibitor of bacterial dihydrofolate reductase.
    Aschhoff HS; Vergin H
    J Antimicrob Chemother; 1979 Nov; 5(B):19-25. PubMed ID: 43863
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines.
    Sirawaraporn W; Sertsrivanich R; Booth RG; Hansch C; Neal RA; Santi DV
    Mol Biochem Parasitol; 1988 Oct; 31(1):79-85. PubMed ID: 3185614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative correlation between molar refractivity and the inhibition of dihydrofolate reductase by 2,4-diamino-5-benzylpyrimidines.
    Kumar NA; Rao MN
    Indian J Biochem Biophys; 1986 Feb; 23(1):58-60. PubMed ID: 3525396
    [No Abstract]   [Full Text] [Related]  

  • 17. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 12. 1,2-Dihydroquinolylmethyl analogues with high activity and specificity for bacterial dihydrofolate reductase.
    Johnson JV; Rauchman BS; Baccanari DP; Roth B
    J Med Chem; 1989 Aug; 32(8):1942-9. PubMed ID: 2666668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and testing of 5-benzyl-2,4-diaminopyrimidines as potential inhibitors of leishmanial and trypanosomal dihydrofolate reductase.
    Chowdhury SF; Guerrero RH; Brun R; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):293-302. PubMed ID: 12683746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationships by neural networks and inductive logic programming. I. The inhibition of dihydrofolate reductase by pyrimidines.
    Hirst JD; King RD; Sternberg MJ
    J Comput Aided Mol Des; 1994 Aug; 8(4):405-20. PubMed ID: 7815092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate.
    Coats EA; Genther CS; Selassie CD; Strong CD; Hansch C
    J Med Chem; 1985 Dec; 28(12):1910-6. PubMed ID: 3934385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.